Dr Reddy’s Laboratories said that after a nod from United States Food & Drug Administration has launched antibiotic Moxifloxacin Hydrochloride Tablets 400 mg in the US.
Dr Reddy�s Laboratories to challenge patents on drugs
Pharma major Dr Reddy’s Laboratories will continue to aggressively challenge patents on drugs in the US despite the recent denial of a 180-day
Pharma major Dr Reddy’s Laboratories will continue to aggressively challenge patents on drugs in the US despite the recent denial of a 180-day
Last week, Dr Reddy’s Laboratories launched anti-migraine sumatriptan injection in the US which clocked $169-million sales in 2013.
Moxifloxacin is an antibiotic which is used for treating acute bacterial sinusitis, bronchitis, skin and abdominal infections.
New and Improved Drug Treatment for Tuberculosis
Bloomberg on Monday examined Bayer's experimental tuberculosis drug moxifloxacin, which could become the first new TB treatment developed in 30 years.
Bloomberg on Monday examined Bayer's experimental tuberculosis drug moxifloxacin, which could become the first new TB treatment developed in 30 years.
Study Finds Antibiotics in US are Often Prescribed Incorrectly
More than one third of antibiotics prescribed in hospitals in the United States might be unnecessary and could be fueling drug resistance, US health authorities.
More than one third of antibiotics prescribed in hospitals in the United States might be unnecessary and could be fueling drug resistance, US health authorities.
Increased Airway Resistance in COPD Occurs Due to Loss or Narrowing of Small Airways
Increase in airway resistance in COPD occurs due to a loss or narrowing of small airways, which precedes the development of emphysema.
Increase in airway resistance in COPD occurs due to a loss or narrowing of small airways, which precedes the development of emphysema.
